Skip to main content

SkinBioTherapeutics

Macclesfield, United Kingdom

The SkinBioTherapeutics platform applies research discoveries made on the activities of lysates derived from probiotic bacteria.

$2.0M raised
Aug 2024
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SkinBioTherapeutics

How much funding has SkinBioTherapeutics raised?
SkinBioTherapeutics has raised $2.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2024.
Who are SkinBioTherapeutics's investors?
SkinBioTherapeutics's investors include Seneca Partners, Premier Miton Investors, Cynosure Capital.
Where is SkinBioTherapeutics headquartered?
SkinBioTherapeutics is headquartered in Macclesfield, United Kingdom.
What does SkinBioTherapeutics do?
The SkinBioTherapeutics platform applies research discoveries made on the activities of lysates derived from probiotic bacteria.
What stage is SkinBioTherapeutics at?
SkinBioTherapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"SkinBioTherapeutics — Funding & Investors." VCBacked, August 2, 2024, https://www.vcbacked.co/company/skinbiotherapeutics. Accessed July 4, 2026.
APA
VCBacked. (2024). SkinBioTherapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/skinbiotherapeutics
Wikipedia (cite web)
{{cite web |title=SkinBioTherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/skinbiotherapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .